Package 62332-567-90

{"route": ["ORAL"], "spl_id": "78cde6f1-5cd7-428e-8ae8-e707d4d5f484", "openfda": {"upc": ["0362332567300", "0362332566303"], "unii": ["DA87705X9K"], "rxcui": ["603203", "603206", "603208"], "spl_set_id": ["ccf1e415-4980-462f-8ac2-87979bda149e"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (62332-567-30)", "package_ndc": "62332-567-30", "marketing_start_date": "20210709"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (62332-567-90)", "package_ndc": "62332-567-90", "marketing_start_date": "20210709"}], "brand_name": "ERLOTINIB HYDROCHLORIDE", "product_id": "62332-567_78cde6f1-5cd7-428e-8ae8-e707d4d5f484", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "62332-567", "generic_name": "ERLOTINIB HYDROCHLORIDE", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ERLOTINIB HYDROCHLORIDE", "active_ingredients": [{"name": "ERLOTINIB HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA214719", "marketing_category": "ANDA", "marketing_start_date": "20210709", "listing_expiration_date": "20261231"}